Cue biopharma to present at the 20th annual pegs boston summit

Boston, may 08, 2024 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific t cells, announced today that it will deliver two poster presentations at the 20th pegs boston summit, the essential protein and antibody engineering summit, being held may 13-17, 2024 in boston, ma and virtually.
CUE Ratings Summary
CUE Quant Ranking